company background image
A271980 logo

Jeil PharmaceuticalLtd KOSE:A271980 Stock Report

Last Price

₩16.35k

Market Cap

₩238.2b

7D

-2.1%

1Y

-13.9%

Updated

07 Apr, 2024

Data

Company Financials

Jeil Pharmaceutical Co.,Ltd

KOSE:A271980 Stock Report

Market Cap: ₩238.2b

A271980 Stock Overview

Jeil Pharmaceutical Co.,Ltd desarrolla y suministra productos farmacéuticos principalmente en Corea del Sur.

A271980 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance2/6
Financial Health3/6
Dividends0/6

Jeil Pharmaceutical Co.,Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Jeil PharmaceuticalLtd
Historical stock prices
Current Share Price₩16,350.00
52 Week High₩22,800.00
52 Week Low₩14,540.00
Beta1.14
1 Month Change-1.33%
3 Month Change-4.50%
1 Year Change-13.95%
3 Year Change-59.68%
5 Year Change-63.13%
Change since IPO-65.21%

Recent News & Updates

Solid Earnings May Not Tell The Whole Story For Jeil PharmaceuticalLtd (KRX:271980)

Mar 19
Solid Earnings May Not Tell The Whole Story For Jeil PharmaceuticalLtd (KRX:271980)

Recent updates

Solid Earnings May Not Tell The Whole Story For Jeil PharmaceuticalLtd (KRX:271980)

Mar 19
Solid Earnings May Not Tell The Whole Story For Jeil PharmaceuticalLtd (KRX:271980)

Shareholder Returns

A271980KR PharmaceuticalsKR Market
7D-2.1%-5.8%-1.5%
1Y-13.9%10.1%7.5%

Rentabilidad frente al sector: A271980 obtuvo unos resultados inferiores a los del sector KR Pharmaceuticals , que el año pasado arrojó un rendimiento del 15.6%.

Rentabilidad vs. Mercado: A271980 obtuvo unos resultados inferiores a los del mercado KR, que fue del 8.1% el año pasado.

Price Volatility

Is A271980's price volatile compared to industry and market?
A271980 volatility
A271980 Average Weekly Movement2.0%
Pharmaceuticals Industry Average Movement4.7%
Market Average Movement5.2%
10% most volatile stocks in KR Market12.0%
10% least volatile stocks in KR Market2.4%

Precio estable de las acciones: A271980 no ha tenido una volatilidad de precios significativa en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de A271980 (6%) se ha mantenido estable durante el año pasado.

About the Company

FoundedEmployeesCEOWebsite
1959964n/ahttps://www.jeilpharm.co.kr

Jeil Pharmaceutical Co.,Ltd desarrolla y suministra productos farmacéuticos principalmente en Corea del Sur. Ofrece productos en las áreas de antibióticos, gastrointestinal, cardiovascular, neuropsiquiatría, oncología, endocrinología, urología, antivirales y antihistamínicos. La empresa también exporta sus productos a unos 40 países de la ASEAN, América Central y del Sur, África y el resto del mundo.

Jeil Pharmaceutical Co.,Ltd Fundamentals Summary

How do Jeil PharmaceuticalLtd's earnings and revenue compare to its market cap?
A271980 fundamental statistics
Market cap₩238.24b
Earnings (TTM)₩5.00b
Revenue (TTM)₩726.39b

47.6x

P/E Ratio

0.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A271980 income statement (TTM)
Revenue₩726.39b
Cost of Revenue₩542.14b
Gross Profit₩184.26b
Other Expenses₩179.25b
Earnings₩5.00b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)343.46
Gross Margin25.37%
Net Profit Margin0.69%
Debt/Equity Ratio37.9%

How did A271980 perform over the long term?

See historical performance and comparison

Dividends

0.3%

Current Dividend Yield

20%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.